PortfoliosLab logoPortfoliosLab logo
BHP vs. NVS
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BHP vs. NVS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BHP Group (BHP) and Novartis AG (NVS). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BHP achieves a 41.38% return, which is significantly higher than NVS's 9.43% return. Over the past 10 years, BHP has outperformed NVS with an annualized return of 21.94%, while NVS has yielded a comparatively lower 10.33% annualized return.


BHP

1D
1.18%
1M
-1.20%
YTD
41.38%
6M
46.29%
1Y
75.94%
3Y*
17.37%
5Y*
14.81%
10Y*
21.94%

NVS

1D
-1.84%
1M
0.27%
YTD
9.43%
6M
15.91%
1Y
27.84%
3Y*
17.18%
5Y*
13.87%
10Y*
10.33%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BHP vs. NVS - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BHP
BHP Group
41.38%28.91%-24.64%16.50%44.34%0.91%25.37%24.50%10.55%33.87%
NVS
Novartis AG
9.43%46.95%0.02%16.14%8.06%-3.65%3.34%13.92%5.95%19.42%

Correlation

The correlation between BHP and NVS is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.29

Correlation (3Y)
Calculated over the trailing 3-year period

0.25

Correlation (5Y)
Calculated over the trailing 5-year period

0.25

Correlation (10Y)
Calculated over the trailing 10-year period

0.28

Correlation (All Time)
Calculated using the full available price history since Nov 8, 1996

0.31

Fundamentals

Market Cap

BHP:

$212.97B

NVS:

$280.54B

EPS

BHP:

$8.51

NVS:

$6.99

PE Ratio

BHP:

9.84

NVS:

20.95

PEG Ratio

BHP:

2.72

NVS:

1.42

PS Ratio

BHP:

1.98

NVS:

5.06

PB Ratio

BHP:

4.23

NVS:

7.28

Total Revenue (TTM)

BHP:

$107.64B

NVS:

$56.05B

Gross Profit (TTM)

BHP:

$89.04B

NVS:

$42.19B

EBITDA (TTM)

BHP:

$52.23B

NVS:

$22.40B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BHP vs. NVS — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BHP
BHP Risk / Return Rank: 9090
Overall Rank
BHP Sharpe Ratio Rank: 9292
Sharpe Ratio Rank
BHP Sortino Ratio Rank: 8989
Sortino Ratio Rank
BHP Omega Ratio Rank: 8787
Omega Ratio Rank
BHP Calmar Ratio Rank: 8888
Calmar Ratio Rank
BHP Martin Ratio Rank: 9393
Martin Ratio Rank

NVS
NVS Risk / Return Rank: 7777
Overall Rank
NVS Sharpe Ratio Rank: 8080
Sharpe Ratio Rank
NVS Sortino Ratio Rank: 7575
Sortino Ratio Rank
NVS Omega Ratio Rank: 7373
Omega Ratio Rank
NVS Calmar Ratio Rank: 7777
Calmar Ratio Rank
NVS Martin Ratio Rank: 7878
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BHP vs. NVS - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BHP Group (BHP) and Novartis AG (NVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


BHPNVSDifference
Sharpe ratioReturn per unit of total volatility

+1.05

Sortino ratioReturn per unit of downside risk

+1.03

Omega ratioGain probability vs. loss probability

1.37

1.24

+0.13

Calmar ratioReturn relative to maximum drawdown

3.86

2.21

+1.65

Martin ratioReturn relative to average drawdown

14.16

5.43

+8.72

BHP vs. NVS - Sharpe Ratio Comparison

The current BHP Sharpe Ratio is 2.41, which is higher than the NVS Sharpe Ratio of 1.36. The chart below compares the historical Sharpe Ratios of BHP and NVS, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


BHPNVSDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

2.41

1.36

+1.05

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.46

0.74

-0.28

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.68

0.53

+0.15

Sharpe Ratio (All Time)

Calculated using the full available price history

0.32

0.42

-0.09

Drawdowns

BHP vs. NVS - Drawdown Comparison

The maximum BHP drawdown since its inception was -76.22%, which is greater than NVS's maximum drawdown of -42.10%. Use the drawdown chart below to compare losses from any high point for BHP and NVS.


Loading charts...

Drawdown Indicators


BHPNVSDifference

Max Drawdown

Largest peak-to-trough decline

-76.22%

-42.10%

-34.12%

Max Drawdown (1Y)

Largest decline over 1 year

-19.80%

-12.65%

-7.15%

Max Drawdown (3Y)

Largest decline over 3 years

-37.21%

-19.95%

-17.26%

Max Drawdown (5Y)

Largest decline over 5 years

-37.21%

-20.42%

-16.79%

Max Drawdown (10Y)

Largest decline over 10 years

-44.29%

-26.03%

-18.26%

Current Drawdown

Current decline from peak

-10.14%

-10.52%

+0.38%

Average Drawdown

Average peak-to-trough decline

-21.29%

-10.93%

-10.36%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.38%

5.14%

+0.24%

Volatility

BHP vs. NVS - Volatility Comparison

BHP Group (BHP) has a higher volatility of 12.75% compared to Novartis AG (NVS) at 6.16%. This indicates that BHP's price experiences larger fluctuations and is considered to be riskier than NVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BHPNVSDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.75%

6.16%

+6.59%

Volatility (6M)

Calculated over the trailing 6-month period

25.95%

14.45%

+11.50%

Volatility (1Y)

Calculated over the trailing 1-year period

31.73%

20.63%

+11.10%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

32.31%

18.85%

+13.46%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

32.31%

19.62%

+12.69%

Dividends

BHP vs. NVS - Dividend Comparison

BHP's dividend yield for the trailing twelve months is around 3.18%, less than NVS's 3.26% yield.


PositionTTM20252024202320222021202020192018201720162015
BHP
BHP Group
3.18%3.64%5.98%4.98%22.44%9.98%3.67%8.59%4.89%3.61%1.68%9.38%
NVS
Novartis AG
3.26%2.90%3.84%3.44%3.70%3.86%3.22%3.03%3.47%3.24%3.73%3.10%

Financials

BHP vs. NVS - Financials Comparison

This section allows you to compare key financial metrics between BHP Group and Novartis AG. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


10.00B15.00B20.00B25.00B30.00B35.00B202120222023202420252026
27.95B
13.52B
(BHP) Total Revenue
(NVS) Total Revenue
Values in USD except per share items

BHP vs. NVS - Profitability Comparison

The chart below illustrates the profitability comparison between BHP Group and Novartis AG over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

40.0%50.0%60.0%70.0%80.0%202120222023202420252026
42.9%
74.4%
Portfolio components
BHP - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, BHP Group reported a gross profit of 11.98B and revenue of 27.95B. Therefore, the gross margin over that period was 42.9%.

NVS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Novartis AG reported a gross profit of 10.07B and revenue of 13.52B. Therefore, the gross margin over that period was 74.4%.

BHP - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, BHP Group reported an operating income of 11.98B and revenue of 27.95B, resulting in an operating margin of 42.9%.

NVS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Novartis AG reported an operating income of 4.24B and revenue of 13.52B, resulting in an operating margin of 31.3%.

BHP - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, BHP Group reported a net income of 5.65B and revenue of 27.95B, resulting in a net margin of 20.2%.

NVS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Novartis AG reported a net income of 3.16B and revenue of 13.52B, resulting in a net margin of 23.3%.


Frequently Asked Questions


BHP and NVS have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BHP has higher volatility (12.75%) compared to NVS (6.16%). In terms of maximum drawdown, BHP dropped -76.22% vs NVS's -42.10%.

BHP currently has the higher Sharpe Ratio (2.41 vs 1.36), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BHP and NVS

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer